Skip to content

InsiderTradesSIGMA

RecommendationsTOP BasketNEW TerminalNEW

Companies Executives Screeners Performance Blog

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Free account open.

FR US DE CH GB CA IT ES NL BE NO FI DK AU AT IE KR IN JP HK+ 23 markets

Recommendations
Terminal
Companies
Insiders
Performance
Backtest
Data quality

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Archive
Insider buying this week
Cluster signals

Methodology
How it works
Glossary
API docs
Blog
RSS
Screeners
Newsletter
Key facts
Data
Insider Confidence Index

About
Contact
Pricing
Sign in
Privacy
Terms
Cookies

Built in Paris. Public sources across 43 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa, among others. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-27. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

© 2026 Insiders TradesΣ·Free account open · Pro on waitlist·Hosted on Vercel

Built bySimon Azoulay

All systems operational

FI-Listed Companies · FIN-FSA · InsiderTrades Sigma · page 21

FI2,780 companies

FI-Listed Companies

Regulator: FIN-FSA.

Santé & Pharma · 64.6B

Technologie · 133.8M

Technologie · 133.8M

Gigasun AB (publ)

Énergie · 115.5M

Gigasun AB (publ)

Gigger Group AB

Gigger Gruop AB

Glaston Oyj Abp

Industrie · 44.6M

Glaston Oyj Abp

Industrie · 45.6M

Glycorex Transplantation

Technologie · 196.1M

Previous 1...10...19 202122 23...30 40 50...56 Next

Goldsky Resources Corp

Chimie & Matériaux · 4.5B

Goldsky Resources Corp

Chimie & Matériaux · 3.8B

Goldsky Resources Corp.

Chimie & Matériaux · 4.5B

Goldsky Resources Corp.

Chimie & Matériaux · 4.5B

Goldsky Resources Corporation

Chimie & Matériaux · 4.2B

Goldsky Resources Corporation

Chimie & Matériaux · 3.9B

Gomero Group AB

Gomspace Group AB

Technologie · 2B

Goobit Group AB (publ)

Finance & Banque

Goobit Group AB (publ)

Finance & Banque · 961.1k

Goodbye Kansas Group AB

Médias & Communication · 59.9M

Goodbye Kansas Group AB

Médias & Communication · 61M

Chimie & Matériaux · 1.7B

Chimie & Matériaux · 1.7B

Greater Than AB

Technologie · 158.1M

Greater Than AB

Technologie · 195.5M

Green Landscaping Group AB (publ)

Industrie · 1.3B

Finance & Banque · 4.6M

Finance & Banque · 5M

GreenMerc AB (Publ

GreenMerc Ab (publ)

GreenMerc Ab (publ)

Finance & Banque · 4.9M

Gruvaktiebolag Viscaria AB

Chimie & Matériaux · 4.7B

Gruvaktiebolag Viscaria AB

Chimie & Matériaux · 4.6B

Gruvaktiebolaget Viscaria

Chimie & Matériaux · 9B

Gruvaktiebolaget Viscaria

Industrie · 7.6B

Gränges AB (publ)

Chimie & Matériaux

Gränges AB (publ)

Chimie & Matériaux · 19.2B

Grängesberg Exploration Holding

Grängesberg Exploration Holding (publ) AB

Grängesberg Exploration Holding (publ.) AB

Grängesberg Exploration Holding AB

Grängesberg Exploration Holding AB (publ)

Grängesberg Exploration Holding AB (publ.)

Grängesberg Rxploration Holding AB (publ)

Gråmunkgränd förvaltningsaktiebolag

Chimie & Matériaux · 42.1M

Gråmunkgränd förvaltningsaktiebolag

Chimie & Matériaux

Guard Therapeutics International AB (publ)

Santé & Pharma · 27M